XML 84 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Contract revenue   $ 6
Type of Revenue [Extensible List] cbio:ContractMember cbio:ContractMember
Operating expenses:    
Research and development $ 43,859 $ 21,474
General and administrative 13,418 12,354
Total operating expenses 57,277 33,828
Loss from operations (57,277) (33,822)
Interest and other income, net 2,099 3,767
Net loss $ (55,178) $ (30,055)
Net loss per share attributable to common stockholders, basic and diluted $ (4.60) $ (2.68)
Shares used to compute net loss per share attributable to common stockholders, basic and diluted 12,004,489 11,213,884